BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24927769)

  • 1. Prevalence of self-reported early glaucoma eye drop bottle exhaustion and associated risk factors: a patient survey.
    Moore DB; Walton C; Moeller KL; Slabaugh MA; Mudumbai RC; Chen PP
    BMC Ophthalmol; 2014 Jun; 14():79. PubMed ID: 24927769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity.
    Sleath B; Blalock S; Covert D; Stone JL; Skinner AC; Muir K; Robin AL
    Ophthalmology; 2011 Dec; 118(12):2398-402. PubMed ID: 21856009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A video study of drop instillation in both glaucoma and retina patients with visual impairment.
    Hennessy AL; Katz J; Covert D; Kelly CA; Suan EP; Speicher MA; Sund NJ; Robin AL
    Am J Ophthalmol; 2011 Dec; 152(6):982-8. PubMed ID: 21821228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating eye drop instillation technique in glaucoma patients.
    Gupta R; Patil B; Shah BM; Bali SJ; Mishra SK; Dada T
    J Glaucoma; 2012 Mar; 21(3):189-92. PubMed ID: 21336146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of the association between patterns of eye drop prescription and medication usage in glaucoma subjects.
    Kawai-Tsuboi N; Kawai M; Minami Y; Yoshida A
    J Glaucoma; 2015 Mar; 24(3):202-6. PubMed ID: 23807351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Association of an Upper Extremity Functional Survey and Glaucoma Medication Administration Success.
    Hein AM; Rosdahl JA; Bosworth HB; Woolson SL; Olsen MK; Kirshner MA; Muir KW
    Curr Eye Res; 2019 Oct; 44(10):1150-1156. PubMed ID: 31157555
    [No Abstract]   [Full Text] [Related]  

  • 7. Factors Affecting Adherence to Topical Glaucoma Therapy: A Quantitative and Qualitative Pilot Study Analysis in Sydney, Australia.
    Spencer SKR; Shulruf B; McPherson ZE; Zhang H; Lee MB; Francis IC; Bank A; Coroneo MT; Agar A
    Ophthalmol Glaucoma; 2019; 2(2):86-93. PubMed ID: 32672609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How glaucoma patient characteristics, self-efficacy and patient-provider communication are associated with eye drop technique.
    Sayner R; Carpenter DM; Robin AL; Blalock SJ; Muir KW; Vitko M; Hartnett ME; Lawrence SD; Giangiacomo AL; Tudor G; Goldsmith JA; Sleath B
    Int J Pharm Pract; 2016 Apr; 24(2):78-85. PubMed ID: 26303667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ability of Bottle Cap Color to Facilitate Accurate Patient-Physician Communication Regarding Medication Identity in Patients with Glaucoma.
    Dave P; Villarreal G; Friedman DS; Kahook MY; Ramulu PY
    Ophthalmology; 2015 Dec; 122(12):2373-9. PubMed ID: 26260280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the Support, Educate, Empower Personalized Glaucoma Coaching Program Pilot Study on Eye Drop Instillation Technique and Self-Efficacy.
    Schneider KJ; Hollenhorst CN; Valicevic AN; Niziol LM; Heisler M; Musch DC; Cain SM; Newman-Casey PA
    Ophthalmol Glaucoma; 2021; 4(1):42-50. PubMed ID: 32781286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of eye drop administration technique in patients with glaucoma or ocular hypertension.
    Schwartz GF; Hollander DA; Williams JM
    Curr Med Res Opin; 2013 Nov; 29(11):1515-22. PubMed ID: 24006861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Relationship of Self-Report and Medication Possession With Glaucoma Medication Administration Success.
    Hein AM; Rosdahl JA; Bosworth HB; Woolson SL; Olsen MK; Kirshner MA; Muir KW
    J Glaucoma; 2019 Mar; 28(3):e46-e48. PubMed ID: 30822299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eye drop instillation technique in patients with glaucoma.
    Tatham AJ; Sarodia U; Gatrad F; Awan A
    Eye (Lond); 2013 Nov; 27(11):1293-8. PubMed ID: 23970024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and determinants of non-adherence to topical hypotensive treatment in Dutch glaucoma patients.
    Olthoff CM; Hoevenaars JG; van den Borne BW; Webers CA; Schouten JS
    Graefes Arch Clin Exp Ophthalmol; 2009 Feb; 247(2):235-43. PubMed ID: 18802720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Eye Drop Instillation Before and After Use of Drop Application Strips in Glaucoma Patients on Chronic Topical Therapy.
    Sharma R; Singhal D; Shashni A; Agarwal E; Wadhwani M; Dada T
    J Glaucoma; 2016 Apr; 25(4):e438-40. PubMed ID: 26550965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Readability of prescription labels and medication recall in a population of tertiary referral glaucoma patients.
    O'Hare F; Jeganathan VS; Rokahr CG; Rogers SL; Crowston JG
    Clin Exp Ophthalmol; 2009 Dec; 37(9):849-54. PubMed ID: 20092593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observed time between prescription refills for newer ocular hypotensive agents: the effect of bottle size.
    Platt R; Reardon G; Mozaffari E
    Am J Ophthalmol; 2004 Jan; 137(1 Suppl):S17-23. PubMed ID: 14697911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mirror-hat device as a drop delivery aid: a pilot study.
    Strungaru MH; Peck J; Compeau EC; Trope GE; Buys YM
    Can J Ophthalmol; 2014 Aug; 49(4):333-8. PubMed ID: 25103649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of an eye drop guide to aid self-administration by patients experienced with topical use of glaucoma medication.
    Salyani A; Birt C
    Can J Ophthalmol; 2005 Apr; 40(2):170-4. PubMed ID: 16049530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drop instillation and glaucoma.
    Davis SA; Sleath B; Carpenter DM; Blalock SJ; Muir KW; Budenz DL
    Curr Opin Ophthalmol; 2018 Mar; 29(2):171-177. PubMed ID: 29140818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.